Medical Devices industry cross border deals total $4.91bn globally in December 2020

Total medical devices industry cross border deals worth $4.91bn were announced globally for December 2020, with the $2.8bn acquisition of BioTelemetry being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked an increase of 918.2% over the previous month of $482.22m and a rise of 108.05% when compared with the last 12-month average of $2.36bn.

In terms of number of cross border deals, the sector saw a drop of 7.89% with 35 deals in December 2020 when compared to the last 12-month average of 38 deals.

In value terms, North America led the activity with cross border deals worth $4.79bn in December 2020.

Medical Devices industry cross border deals in December 2020: Top deals

The top five cross border deals accounted for 85.8% of the overall value during December 2020.

The combined value of the top five cross border deals stood at $4.21bn, against the overall value of $4.91bn recorded for the month.

The top five medical devices industry cross border deals of December 2020 tracked by GlobalData were:

1) Koninklijke Philips’ $2.8bn acquisition of BioTelemetry

2) The $700m private equity deal with Verily Life Sciences by Alphabet, Ontario Teachers’ Pension Plan, Silver Lake Partners and Temasek Holdings (Private)

3) Richter Gedeon Nyrt’s $263.5m asset transaction with Janssen Pharmaceutica

4) The $250m acquisition deal of EmendoBio by AnGes

5) Baillie Gifford, Franklin Templeton Investments, Google, Novo Holdings and T Rowe Price Associates’ venture financing deal with Tempus Labs for $200m.